Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Ronzoni

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
JHEP Reports : Innovation in Hepatology|October 31, 2022
Clinical and genetic determinants of the fatty liver-coagulation balance interplay in individuals with metabolic dysfunctionLuca Valenti, Armando Tripodi, Vincenzo La Mura, et al.
Transfusion|October 14, 2021
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donorsLuca Valenti, Serena Pelusi, Alessandro Cherubini, et al.
Scientific Reports|May 6, 2025
The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patientsTimo Mayerhöfer, Michael Joannidis, Sebastian Klein, et al.
Egastroenterology|February 13, 2025
ABCC2 p.R393W variant contributes to Dubin-Johnson syndrome by targeting MRP2 to proteasome degradationRong-Yue Sun, Yi-Ming Chen, Mian-Mian Zhu, et al.
Science Translational Medicine|September 10, 2025
Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitisHongxue Shi, Xiaobo Wang, Christopher Sloas, et al.
United European Gastroenterology Journal|December 23, 2023
Predictors of controlled attenuation parameter in metabolic dysfunctionCristiana Bianco, Serena Pelusi, Sara Margarita, et al.
Plos One|August 12, 2010
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursorsSilverio Perrotta, Valeria Cucciolla, Marcella Ferraro, et al.
Hepatology (Baltimore, Md.)|May 22, 2024
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulationMary P Moore, Xiaobo Wang, John Paul Kennelly, et al.
International Journal of Molecular Sciences|January 28, 2026
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation ModulationFrancesco Malvestiti, Angela Lombardi, Francesco Gentile, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
JHEP Reports : Innovation in Hepatology|October 31, 2022
Clinical and genetic determinants of the fatty liver-coagulation balance interplay in individuals with metabolic dysfunctionLuca Valenti, Armando Tripodi, Vincenzo La Mura, et al.
Transfusion|October 14, 2021
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donorsLuca Valenti, Serena Pelusi, Alessandro Cherubini, et al.
Scientific Reports|May 6, 2025
The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patientsTimo Mayerhöfer, Michael Joannidis, Sebastian Klein, et al.
Egastroenterology|February 13, 2025
ABCC2 p.R393W variant contributes to Dubin-Johnson syndrome by targeting MRP2 to proteasome degradationRong-Yue Sun, Yi-Ming Chen, Mian-Mian Zhu, et al.
Science Translational Medicine|September 10, 2025
Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitisHongxue Shi, Xiaobo Wang, Christopher Sloas, et al.
United European Gastroenterology Journal|December 23, 2023
Predictors of controlled attenuation parameter in metabolic dysfunctionCristiana Bianco, Serena Pelusi, Sara Margarita, et al.
Plos One|August 12, 2010
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursorsSilverio Perrotta, Valeria Cucciolla, Marcella Ferraro, et al.
Hepatology (Baltimore, Md.)|May 22, 2024
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulationMary P Moore, Xiaobo Wang, John Paul Kennelly, et al.
International Journal of Molecular Sciences|January 28, 2026
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation ModulationFrancesco Malvestiti, Angela Lombardi, Francesco Gentile, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Pageof 5